Cite
HARVARD Citation
Michallet, A. et al. (n.d.). Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real‐world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group. American journal of hematology. 92 (6), pp. E105-E107. [Online].